Skip to main content
Liver Cancer logoLink to Liver Cancer
. 2022 Oct 4;11(6):581. doi: 10.1159/000525946

Erratum

PMCID: PMC9801174  PMID: 36589731

In the article by Uojima et al. entitled “Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib” [Liver Cancer. 2020; 9:193–206, DOI: 10.1159/000504604], the authors found that “SMI = subcutaneous fat area (cm2) / height2 (m2)” was used erroneously instead of “SMI = skeletal mass area (cm2) / height2 (m2)” in the labelling of Figure 2. Figure 2 with the correct labelling is shown here.

Fig. 2.

Fig. 2

Cross-sectional areas of skeletal muscle at the third lumbar level were measured by manual tracing on the CT images, and their sum was calculated. The green area indicates skeletal muscle at the third lumbar level. SMI, skeletal muscle index.


Articles from Liver Cancer are provided here courtesy of Karger Publishers

RESOURCES